Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
IM Cannabis Corp ( (IMCC) ) has issued an announcement.
On July 1, 2025, IM Cannabis Corp. announced that it received a deficiency letter from Nasdaq on April 9, 2025, for not meeting the minimum stockholders’ equity requirement for continued listing. The company submitted a compliance plan on May 23, 2025, and was granted an extension until October 6, 2025, to meet the requirements. Failure to comply by the deadline may result in delisting, although the company’s shares will continue trading under the symbol ‘IMCC’. IM Cannabis is committed to taking all reasonable measures to regain compliance, but there is no assurance of success.
The most recent analyst rating on (IMCC) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Neutral.
IM Cannabis Corp’s overall score is heavily impacted by its poor financial performance, which poses significant risks. The company’s earnings call provided a positive outlook with improvements in profitability and strategic focus on the German market. However, the technical analysis and valuation remain weak, thereby limiting the overall appeal of the stock.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is a leading medical cannabis company with operations in Israel and Germany. It focuses on providing medical cannabis products to patients in these regions, leveraging a transnational ecosystem powered by data-driven approaches and a globally sourced product supply chain. The company operates through subsidiaries in Israel, distributing cannabis to medical patients and managing retail pharmacies, online platforms, and distribution centers. In Germany, it operates through Adjupharm GmbH, distributing cannabis to pharmacies.
Average Trading Volume: 253,265
Technical Sentiment Signal: Hold
Current Market Cap: $8.16M
For detailed information about IMCC stock, go to TipRanks’ Stock Analysis page.